MOE AMADPOUR, M.D.
Gastroenterology Physician in SIMI VALLEY, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
MOE AMADPOUR, M.D. reported a CMS MIPS final score of 75/100 — below the 83.1 national average — and filed 3,265 Medicare Part D claims in 2023.
- 75/100
- MIPS score · -8 vs avg
- 3K
- Part D claims, 2023
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
MOE AMADPOUR, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
75 15th percentile higher than 15% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
MOE AMADPOUR, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about MOE AMADPOUR, M.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in California
How Gastroenterology Physician compares to other specialties among California providers
Gastroenterology Physician share within California
Gastroenterology Physician is one of the more visible NUCC categories in California
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
MOE AMADPOUR, M.D.'s 2023 MIPS final score plotted against the Gastroenterology Physician national average
- MIPS Final Score
- 75/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Gastroenterology Physician) — 75/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Specialty volume Gastroenterology Physician US NPIs
75/100 MIPS final score — 8.1 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Gastroenterology Physician.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MOE AMADPOUR, M.D. appears in the CMS NPPES registry as a Gastroenterology Physician provider holding M.D. credentials at 1159 ROADRUNNER WAY, SIMI VALLEY, CA, 93065, with a listed phone of (805) 583-2643. NPI 1508965476 was issued on 09/21/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what AMADPOUR most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 3,265 prescription claims written by this provider, covering 678 Medicare beneficiaries and totaling roughly $1.5 million in drug spend, with an opioid prescribing rate of 0.7%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.
Gastroenterology Physician is a mid-sized specialty nationwide, with 16,567 enrolled providers across 54 states and an average of 833 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1508965476 |
|---|---|
| Specialty | Gastroenterology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 09/21/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MOE AMADPOUR, M.D.'s current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MOE AMADPOUR, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$3.3K
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — California MBC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to MOE AMADPOUR, M.D.. To verify MOE AMADPOUR, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 5,368
- Total Day Supply
- 146,065
- Generic Drug Cost
- $220K
- Opioid Claims
- 22 (0.7% rate)
- Antibiotic Claims
- 105
Patient Demographics
- Average Patient Age
- 72.0 years
- Avg HCC Risk Score
- 1.28
- Gender Split
- 61% female / 39% male
- Age Distribution
- <65: 83, 65-74: 338, 75-84: 210, 85+: 47
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What MOE AMADPOUR, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Pantoprazole Sodium
Pantoprazole Sodium
1,079 claims
- Dexlansoprazole Dr 177
Dexlansoprazole Dr
177 claims
- Linzess 147
Linzess
147 claims
- Sodium Chloride 95
Sodium Chloride
95 claims
- Famotidine 84
Famotidine
84 claims
- Omeprazole 72
Omeprazole
72 claims
- Ondansetron Hcl 71
Ondansetron Hcl
71 claims
- Metoclopramide Hcl 63
Metoclopramide Hcl
63 claims
| Drug | Claims |
|---|---|
| Pantoprazole Sodium | 1,079 |
| Dexlansoprazole Dr Dexlansoprazole | 177 |
| Linzess Linaclotide | 147 |
| Sodium Chloride 0.9 % Sodium Chloride | 95 |
| Famotidine | 84 |
| Omeprazole | 72 |
| Ondansetron Hcl | 71 |
| Metoclopramide Hcl | 63 |
| Promethazine Hcl | 63 |
| Sucralfate | 62 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Gastroenterology Physician Overview
How MOE AMADPOUR, M.D. fits within the Gastroenterology Physician landscape nationally.
MOE AMADPOUR, M.D.'s 3,265 claims are above the specialty average of 833.
Nearby Gastroenterology Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as AMADPOUR.
Compare Gastroenterology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore California
Frequently Asked Questions
What is MOE AMADPOUR, M.D.'s specialty? ▼
How much does MOE AMADPOUR, M.D. prescribe under Medicare Part D? ▼
What is MOE AMADPOUR, M.D.'s Medicare quality score? ▼
Where is MOE AMADPOUR, M.D. located? ▼
What is MOE AMADPOUR, M.D.'s NPI number? ▼
Does MOE AMADPOUR, M.D. prescribe opioids? ▼
How many Gastroenterology Physician providers are there in the US? ▼
What drugs does MOE AMADPOUR, M.D. prescribe most often? ▼
Does MOE AMADPOUR, M.D. accept Medicare? ▼
How can I verify MOE AMADPOUR, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology